Maral M. Mıldanoglu
Istanbul, 34214, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Revisiting Platinum Sensitivity in Relapsed Small-Cell Lung Cancer: Outcomes of Platinum-Containing Doublet Chemotherapy in the 3-6 Month Relapse Window.
Journal: Current oncology (Toronto, Ont.)
Published: June 18, 2026
Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO).
Journal: JCO global oncology
Published: March 26, 2026
Molecular Profiling and Survival Outcomes in Pancreatic Ductal Adenocarcinoma: A Multicenter Real-World Study from Turkey.
Journal: Current oncology (Toronto, Ont.)
Published: March 11, 2026
Combined Lung Immune Prognostic Index (LIPI)-Glasgow Prognostic Score (GPS) as a Prognostic Tool in Extensive-Stage Small-Cell Lung Cancer Treated with First-Line Chemo-Immunotherapy.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 04, 2026
A Novel Biological Index for Predicting Neoadjuvant Treatment Response in HER2-Positive Breast Cancer: The Tumor-Immune-Proliferation-Inflammation (TIPI) Score.
Journal: Journal of clinical medicine
Published: February 28, 2026
Prognostic Significance of Frailty in Liver Cirrhosis Patients: A Prospective Single-Center Study.
Journal: Journal of clinical medicine
Published: February 12, 2026
Immunotherapy Versus Chemo-Immunotherapy as First-Line Treatment in Metastatic Non-Small Cell Lung Cancer Patients with PD-L1 TPS ≥ 50%: A Real-World Retrospective Study.
Journal: Journal of clinical medicine
Published: February 11, 2026
Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study (TOG/GI-SAFRADJU-2501).
Journal: International journal of cancer
Published: February 09, 2026
Real-world outcomes of trifluridine/tipiracil with or without bevacizumab in refractory metastatic colorectal cancer: a multicenter cohort study from Turkey.
Journal: Discover oncology
Published: February 09, 2026
Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG).
Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology
Published: April 17, 2025
Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) study.
Journal: Scientific reports
Published: April 04, 2025
Last Updated: 09/26/2026